10.28.25 -- FDA Cracks Down On GLP-1 Imports

AI and MES can’t meet pharma’s visual inspection demands. Discover how purpose-built software ensures defect detection, compliance, and paperless quality for safer, more efficient operations.

Paper-based processes slow down life sciences manufacturing and introduce compliance risks. Uncover how digital procedures and electronic logbooks can boost accuracy, speed, and traceability.

CMOs specializing in sterile injectable filling help pharmaceutical companies speed up development and commercialization through flexible manufacturing, adaptability, and strong collaboration.

Physiologically based pharmacokinetic modeling is a powerful tool for clinical trial design that can be leveraged alongside early development experiments to reduce costs and accelerate timelines.

Proactive seal replacement in biopharmaceutical manufacturing prevents costly failures and downtime, ensuring product quality and process integrity.

In this survey, 200+ people involved in the oral dose market shared their views on barriers to the development of oral formulations and technological responses to them.

Find out how advanced API-in-capsule technology addresses previous limitations, providing a flexible and efficient path for drug candidates from development to clinical trials.

Steven Facer and Laxxon Medical COO Klaus Kühne describe the capabilities of 3D screen printing for pharmaceutical production. Explore prototyping, IP protection, release profile possibilities, and more.

Watch to learn more about intensified downstream bioprocessing in-depth and take the first step toward a more innovative and efficient future in bioprocessing.

Examine overlooked contamination sources, like residues, poor housekeeping, and training gaps, which offer practical strategies to strengthen your contamination control program.

Expression of inclusion bodies has historically suffered a bad reputation in the industry. So, how do these two routes, soluble and insoluble, compare in terms of their advantages and challenges?

Review the differences between research-use-only oligonucleotides and those manufactured in compliance with GMP 21 CFR 820.

Delve into a reliable solution for labeling small batches of medical products, including vials, syringes, and cartridges, that fully automatic machines struggle to handle.

Gain insight into the development of a mobile Biosafety Level 2+ (BSL-2+) facility adhering to cGMP for early-phase clinical trial manufacturing.